Author

Daniela Tudor

Centre National de la Recherche ScientifiqueORCID 0000-0002-8281-4600Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Daniela Tudor1 paper · University of Bucharest

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Andréa Cottignies-CalamarteiD· 1 shared Benoît ViolletiD· 1 shared Feifan He· 1 shared Flora MarteauiD· 1 shared Jean DubuissoniD· 1 shared Morgane BomseliD· 1 shared Sandrine BelouzardiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andréa Cottignies-CalamarteORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response

Andréa Cottignies-Calamarte, Flora Marteau, Feifan He, Sandrine Belouzard, Jean Dubuisson, Daniela Tudor, Benoît Viollet, Morgane Bomsel

This paper shows that MK-8722, a direct AMPK activator, inhibits SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy, and enhancing type I IFN response, even when applied post-exposure.

Journal of Virology · Jun 12, 2025Peer-reviewedImmunology